Streetwise Interviews

Jack Chan

Jack Chan: 2016 Year-End Review and Forward Analysis for 2017
Source: Jack Chan for Streetwise Reports  (1/1/17)
Technical analyst Jack Chan looks back on the precious metals and energy markets in 2016, as well as forward into 2017. More >

Lior Gantz

These Resource Sectors Will Soar in 2017
Source: Lior Gantz for The Gold Report  (12/28/16)
A perfectly timed opportunity and a deep-value contrarian speculation are setting up in the resource sector, says Lior Gantz, editor of Wealth Research Group. More >

Manganese X Sets Sights on Becoming a Major North American Producer
Source: The Energy Report  (12/28/16)
As manganese gains attention as a potential major component in the next generation of battery technology, Manganese X Energy Corp. is moving rapidly into the North American manganese market. More >

Adrian Day

Year-End Spinoff and Merger Updates
Source: Adrian Day for The Gold Report  (12/28/16)
Money manager Adrian Day comments on Yamana Gold's spinoff purchase rights and the American Capital/Ares Capital merger. More >

Kenneth Ameduri

Silver Will Trump Gold in 2017
Source: Kenneth Ameduri for The Gold Report  (12/27/16)
Kenneth Ameduri, editor of, argues that silver markets will see a surge during the Trump administration. More >

Jack Chan

Jack Chan: This Past Week in Gold
Source: Jack Chan for The Gold Report  (12/24/16)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets. More >

An Uptick in Brucejack Resource Estimates Bodes Well for Pretium Resources
Source: The Gold Report  (12/22/16)
Upward revision of gold reserves estimates at Pretium Resources' Valley of the Kings deposit, along with announcement of a management change, caught the attention of a handful of analysts, who offered their takes on future development of the Brucejack mine.
More >

Viveve's Technology for Women's Sexual Dysfunction Receives Regulatory Approval in 49 Countries
Source: The Life Sciences Report  (12/21/16)
The last several months have been active ones for Viveve: The results of the VIVEVE I clinical trial were accepted for publication in the Journal of Sexual Medicine, third-quarter financial results beat expectations, and the Viveve system has received regulatory approvals in Brazil, U.A.E. and Lebanon and FDA 510(k) clearance in the U.S. More >

VistaGen Licenses Stem Cell Technology to New Firm Backed by Big Pharma
Source: The Life Sciences Report  (12/21/16)
VistaGen Therapeutics has granted an exclusive sublicense for its stem cell technologies to BlueRock Therapeutics, a new biotech backed by pharma heavyweight Bayer AG and venture capital firm Versant Ventures of San Francisco. More >

Michael Ballanger

'Twas the Week Before Christmas. . .
Source: Michael J. Ballanger for The Gold Report  (12/20/16)
Precious metals expert Michael Ballanger compares the current state of the precious metals market to one year ago. More >

Momentum Is Building at Nemaska Lithium's Mine and Plant
Source: The Energy Report  (12/20/16)
Nemaska Lithium's progress on the Whabouchi lithium project and the Shawinigan Phase 1 Plant has garnered the attention of several analysts. More >

The War on Cash and Then on Gold
Source: Clive Maund for The Gold Report  (12/19/16)
Technical analyst Clive Maund says liquidity issues with banks could lead to restrictions on cash and precious metals. More >

Jack Chan

Jack Chan: This Past Week in Gold
Source: Jack Chan for The Gold Report  (12/17/16)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets, noting a bull market has emerged for the U.S. dollar. More >

Columbus Gold Gains Attention with Montagne d'Or Takeover Potential and Nevada Upside
Source: The Gold Report  (12/15/16)
Experts are speculating that Columbus Gold's Montagne d'Or project in French Guiana is a prime takeover target for Nord Gold, while the recently released maiden resource estimate for Eastside in Nevada underlines the potential for this early-stage development project. More >

Disruptive Biotech and Technology Platform Sets Up 3D Signatures for Explosive Growth
Source: The Life Sciences Report  (12/14/16)
3D Signatures, a Canadian company developing a platform of "disruptive" personalized prognostic tests for patients with 13 different cancers and Alzheimer's disease, has attracted the attention of several stock watchers with its most recent announcements.
More >

Adrian Day

Adrian Day: Sell Yamana Rights, When You Can, For What You Can
Source: Adrian Day for The Gold Report  (12/12/16)
Money manager Adrian Day shares his advice to Yamana shareholders on how to handle the Brio spinoff. More >

Jack Chan

Jack Chan: Gold and Silver Are on Long- and Short-Term Buy Signals
Source: Jack Chan for The Gold Report  (12/10/16)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets. More >

Drilling Advances Pershing Gold's Relief Canyon
Source: The Gold Report  (12/8/16)
Pershing Gold's advancements in the Relief Canyon project in Nevada over the last month have caught the attention of several analysts. More >

Why the Canadian Marijuana Sector Is the Next Big Thing and Why Emblem Is Our Top Pick
Source: Gecko Research for Streetwise Reports  (12/8/16)
Gecko Research discusses the bull market for marijuana, the road to legalization in Canada and why Emblem Corp., which begins trading on the TSX.V on Dec. 12 under the symbol EMC, is their top pick. More >

Daniel Ameduri

Gold to Explode After Second Rate Hike
Source: Daniel Ameduri for The Gold Report  (12/8/16)
Daniel Ameduri, founder of the Wealth Research Group, traces the correlation between Fed rate hikes and the trajectory of the gold markets, predicting a long-term bullish period for the precious metal. More >

Reliq Health Technologies Pilots Remote Patient Monitoring Program
Source: The Life Sciences Report  (12/7/16)
Reliq Health Technologies is initiating a trial of its remote patient monitoring system with The Feldman Institute in Louisiana, the fourth program for the company's innovative technology. More >

Adrian Day

Major Royalty Companies Are Good Buys Now
Source: Adrian Day for The Gold Report  (12/5/16)
Adrian Day reviews recent results at some of his favorite gold and silver royalty and streaming companies and asserts that they represent, as a group, the lowest risk way to gain exposure to the sector. More >

Jack Chan

Jack Chan: This Past Week in Gold
Source: Jack Chan for The Gold Report  (12/3/16)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets. More >

Jack Chan

Jack Chan: This Past Week in Energy
Source: Jack Chan for The Energy Report  (12/3/16)
Technical analyst Jack Chan charts a major buy signal in the energy market. More >

Can Biotech's Trump Bump Last?
Source: The Life Sciences Report  (12/2/16)
In the weeks since Donald Trump's presidential election victory, the stock markets have ridden a wave into positive—and in the case of the Dow, record-breaking—territory. The so-called Trump Bump also sent biotech indices, flaccid for much of the year, up as much as 15%. With the election now nearly a month old, and hot-button issues such as drug pricing still in the press, industry watchers have begun to weigh in on what might happen in the biotech and pharma markets when Trump takes office. More >

Showing Results: 26 to 50 of 2251 Prev Next